Filter News
Area of Research
News Topics
- (-) 3-D Printing/Advanced Manufacturing (3)
- (-) Artificial Intelligence (3)
- (-) Biomedical (3)
- Advanced Reactors (3)
- Big Data (6)
- Computer Science (17)
- Coronavirus (4)
- Cybersecurity (1)
- Exascale Computing (2)
- Fusion (5)
- Grid (1)
- High-Performance Computing (1)
- Isotopes (2)
- Machine Learning (2)
- Materials Science (5)
- Mathematics (1)
- Molten Salt (1)
- Nanotechnology (1)
- Neutron Science (3)
- Nuclear Energy (11)
- Physics (2)
- Quantum Science (4)
- Space Exploration (1)
- Summit (5)
- Transformational Challenge Reactor (2)
- Transportation (1)
Media Contacts
A multi-institutional team, led by a group of investigators at Oak Ridge National Laboratory, has been studying various SARS-CoV-2 protein targets, including the virus’s main protease. The feat has earned the team a finalist nomination for the Association of Computing Machinery, or ACM, Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research.
ORNL and three partnering institutions have received $4.2 million over three years to apply artificial intelligence to the advancement of complex systems in which human decision making could be enhanced via technology.
It’s a new type of nuclear reactor core. And the materials that will make it up are novel — products of Oak Ridge National Laboratory’s advanced materials and manufacturing technologies.
Scientists at the Department of Energy Manufacturing Demonstration Facility at ORNL have their eyes on the prize: the Transformational Challenge Reactor, or TCR, a microreactor built using 3D printing and other new approaches that will be up and running by 2023.
In the race to identify solutions to the COVID-19 pandemic, researchers at the Department of Energy’s Oak Ridge National Laboratory are joining the fight by applying expertise in computational science, advanced manufacturing, data science and neutron science.
As the second-leading cause of death in the United States, cancer is a public health crisis that afflicts nearly one in two people during their lifetime.